Homebiopharmaceutical

biopharmaceutical

EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm

EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm

December 16, 2022

ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

December 16, 2022

Ultragenyx’s (RARE) Portfolio of Marketed Drugs Aids Growth

Ultragenyx’s (RARE) Portfolio of Marketed Drugs Aids Growth

December 16, 2022

AbCellera (ABCL) to Develop New Antibody Therapies With AbbVie

AbCellera (ABCL) to Develop New Antibody Therapies With AbbVie

December 16, 2022

Here’s Why Affimed N.V. (AFMD) is Poised for a Turnaround After Losing 47.1% in 4 Weeks

Here’s Why Affimed N.V. (AFMD) is Poised for a Turnaround After Losing 47.1% in 4 Weeks

December 16, 2022

Oncocyte Announces Initiatives to Focus Corporate Strategy

Oncocyte Announces Initiatives to Focus Corporate Strategy

December 16, 2022

ASLAN Pharmaceuticals Announces Participation in January Investor Conferences

ASLAN Pharmaceuticals Announces Participation in January Investor Conferences

December 16, 2022

Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities

Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities

December 16, 2022

Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt

Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt

December 16, 2022

Kymera (KYMR) Up on Positive Data From Phase I Study on KT-474

Kymera (KYMR) Up on Positive Data From Phase I Study on KT-474

December 15, 2022

« 1 … 9 10 11 12 13 … 558 »